Biocon founder and chairperson Kiran Mazumdar-Shaw's niece Claire Mazumdar's company Bicara Therapeutics made its debut at ...

BingEx is seeking a valuation of up to $78.2 million in its initial public offering. The Chinese on-demand courier-service provider will offer up to 4.6 million American depositary shares, expecting ...

Kiran Mazumdar-Shaw accompanied her niece in ringing the opening bell at the Nasdaq headquarters in New York City, marking a ...

Biotech IPOs are making a comeback alongside the sector’s recent gains as funding constraints fueled by record-high interest ...

Black Spade Acquisition II Co (the "Company") (NASDAQ: BSIIU), a special purpose acquisition company ("SPAC"), today ...

We recently published a list of Top 10 Buzzing AI Stocks Now. Since Astera Labs Inc (NASDAQ:ALAB) ranks 10th on the list, it ...

Bicara Therapeutics, a clinical-stage biopharmaceutical company, focuses on brining transformative bifunctional therapies for ...

For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Metagenomi, Inc. (NASDAQ: MGX) ...

On September 25, 2024, BARD ASSOCIATES INC (Trades, Portfolio), a notable investment firm, executed a significant transaction ...

Starbucks' valuation and forecasts are not compelling enough to take this turnaround risk. Learn why SBUX stock is a Sell.

Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...

By Arasu Kannagi Basil and Prakhar Srivastava (Reuters) -Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer ...